Xenon Pharmaceuticals Inc. held its 2025 Annual Meeting of Shareholders on June 4, 2025. At the meeting, several proposals were voted on. The election of directors was approved, with all nominees being elected. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the ensuing year was also approved. Additionally, the authority of the audit committee to set the remuneration of the auditor for the upcoming year was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.